MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • 2025 International Congress

    Is It Better to Sing Together? A Review of Choral Singing for People with Parkinson’s Disease

    S. Kolipaka, H. Kong, P. Izbicki (Boca Raton, USA)

    Objective: This review assesses the effects of choral singing as an adjunct therapy for Parkinson’s disease (PD). Background: PD is the second-most common neurodegenerative disease,…
  • 2025 International Congress

    EEG connectivity in Parkinson disease: a comparative analysis of sporadic and genetic forms in ON/OFF therapy.

    M. Treddenti, V. Yahya, S. Marceglia, V. D'Onofrio, A. Guerra, T. Bocci, A. Priori (Milan, Italy)

    Objective: The study aims to compare the connectivity profile of patients affected by sporadic and genetic Parkinson's disease in different levodopa conditions through the analysis…
  • 2025 International Congress

    Freezing of Gait Detection and Warning System for Parkinson’s Patients

    D. Kusbeci, T. Ozkarslioglu, N. Durmaz Celik, Z. Saatci (Izmir, Turkey)

    Objective: This study aims to mitigate the adverse effects of FOG through a novel, wearable device designed for real-time detection and intervention. Background: One of…
  • 2025 International Congress

    IncobotulinumtoxinA to Treat Sialorrhea in Parkinson’s Disease: a Real-life Study: 6-year Interim Results

    B. Bergmans, N. Winter, V. Schotte, N. Sys, E. van Massenhove, G. Pollet, H. Couckuyt, L. Delameilleure, M. van Zandijcke (Bruges, Belgium)

    Objective: We evaluate the long-term efficacy and safety of incobotulinumtoxinA injections in advanced Parkinson’s disease (PD) patients suffering from sialorrhea. Background: Sialorrhea is frequently a…
  • 2025 International Congress

    Changes in Motor States Throughout the Waking Day With Tavapadon in People With Parkinson’s Disease

    R. Hauser, R. Pahwa, L. Harmer, A. Lind (Tampa, USA)

    Objective: To evaluate motor states throughout the waking day when adding tavapadon to oral carbidopa/levodopa in adults with Parkinson’s disease experiencing motor fluctuations. Background: Long-term…
  • 2025 International Congress

    Increasing Physical Activity in Parkinson’s Disease Via a Remotely Deployed Gamification Intervention

    J. Morley, K. Waddell, M. Smith, S. Wood, R. Greysen (Philadelphia, USA)

    Objective: To determine feasibility and estimate effect of a remote behavioral intervention on daily steps and motor symptoms in Veterans with PD Background: Many types…
  • 2025 International Congress

    Efficacy and safety of Rotigotine Extended-Release Microspheres in Early Parkinson’s Disease

    H. Sun, X. Dan, H. Chen, J. Feng, W. Wang, Q. Ye, Y. Liu, C. Liu, S. Chen, P. Chan (Beijing, China)

    Objective: To assess the efficacy and safety of Rotigotine extended-release microspheres (LY03003) in patients with early Parkinson's disease Background: Treatment that provides a continuous flow of…
  • 2025 International Congress

    Exploring minzasolmin effect on digital measures captured by the Verily Study Watch in a subset of the ORCHESTRA trial participants

    B. Bloem, V. Hinson, E. Goikoetxea, L. Gaetano, K. Ray, F. Ambrosetti, KC. Ho, M. Key Prato, A. Pethe, V. Ticcinelli, J. Trzebinski, S. Warma, A. Khanna, Z. Ali (Nijmegen, Netherlands)

    Objective: To investigate the progression over time and the effect of minzasolmin on digital outcomes collected in ORCHESTRA (NCT04658186). Background: Minzasolmin is an oral small…
  • 2025 International Congress

    Continued Evaluation of Bemdaneprocel Following a Phase 1 Study for Parkinson’s Disease: Outcomes Through 3 Years

    H. Sarva, C. Henchcliffe, A. Lozano, A. Fasano, S. Kalia, K. Yu, C. Brennan, W. Stemple, N. Floro, N. Abid, V. Tabar (New York, USA)

    Objective: To report the safety and clinical outcomes of bemdaneprocel in participants with Parkinson’s disease (PD) through 3 years post transplantation. Background: Bemdaneprocel is an…
  • 2025 International Congress

    Does the cerebellum compensate to enable motor learning in Parkinson’s Disease?

    PC. Iyer, BE. Fisher (Los Angeles, USA)

    Objective: To test the causal relation between cerebellar function and learning in PD. Background: Neuroimaging studies reveal that people with Parkinson’s disease (PwPD) exhibit increased…
  • « Previous Page
  • 1
  • …
  • 6
  • 7
  • 8
  • 9
  • 10
  • …
  • 436
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley